Search research articles
Contact Us
Filters
Showing results (51-60 of 231) with videos related to
Page
of 24
Sort By:
Journal of the National Cancer Institute
|
November 20, 2024
First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors
Megan Othus, Sandip P Patel, Young Kwang Chae, et al.
Ophthalmic Epidemiology
|
December 12, 2022
Seasonal Variation in the Diagnosis of Retinoblastoma
Shonar Singh, Thamanna Nishath, Ido Didi Fabian, et al.
American Journal of Hematology
|
January 3, 2014
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Sarah A Buckley, Megan Othus, Vladimir Vainstein, et al.
Leukemia & Lymphoma
|
March 3, 2015
Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission
Merav Bar, Megan Othus, Hanahlyn M Park, et al.
Blood
|
June 18, 2011
Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation
Min Fang, Barry Storer, Elihu Estey, et al.
Journal of the National Cancer Institute
|
January 20, 2024
Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial
Megan Othus, Sandip P Patel, Young K Chae, et al.
Leukemia & Lymphoma
|
February 9, 2021
Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203
Anna Moseley, Megan Othus, Guillermo Garcia-Manero, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 30, 2024
Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions
Anna B Halpern, Jessica M Sugalski, Lindsey Bandini, et al.
Leukemia & Lymphoma
|
February 26, 2013
Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study
Tara L Chen, Elihu H Estey, Megan Othus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multi-Center Basket Trial Analysis (NCI/SWOG S1609)
Manmeet S Ahluwalia, Sophie Solomon, Sandip P Patel, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 231) with videos related to
Sort By:
Page
of 24
Journal of the National Cancer Institute
|
November 20, 2024
First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors
Megan Othus, Sandip P Patel, Young Kwang Chae, et al.
Ophthalmic Epidemiology
|
December 12, 2022
Seasonal Variation in the Diagnosis of Retinoblastoma
Shonar Singh, Thamanna Nishath, Ido Didi Fabian, et al.
American Journal of Hematology
|
January 3, 2014
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Sarah A Buckley, Megan Othus, Vladimir Vainstein, et al.
Leukemia & Lymphoma
|
March 3, 2015
Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission
Merav Bar, Megan Othus, Hanahlyn M Park, et al.
Blood
|
June 18, 2011
Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation
Min Fang, Barry Storer, Elihu Estey, et al.
Journal of the National Cancer Institute
|
January 20, 2024
Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial
Megan Othus, Sandip P Patel, Young K Chae, et al.
Leukemia & Lymphoma
|
February 9, 2021
Predicting severe toxicities with intensive induction chemotherapy for adult acute myeloid leukemia: analysis of SWOG Cancer Research Network trials S0106 and S1203
Anna Moseley, Megan Othus, Guillermo Garcia-Manero, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 30, 2024
Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions
Anna B Halpern, Jessica M Sugalski, Lindsey Bandini, et al.
Leukemia & Lymphoma
|
February 26, 2013
Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study
Tara L Chen, Elihu H Estey, Megan Othus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multi-Center Basket Trial Analysis (NCI/SWOG S1609)
Manmeet S Ahluwalia, Sophie Solomon, Sandip P Patel, et al.
Page
of 24